chr7-107283630-C-CG
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000297135.9(COG5):βc.1415_1416insCβ(p.Gly474TrpfsTer3) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000868 in 1,613,730 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Synonymous variant affecting the same amino acid position (i.e. P472P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000297135.9 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COG5 | NM_006348.5 | c.1415_1416insC | p.Gly474TrpfsTer3 | frameshift_variant | 13/22 | ENST00000297135.9 | NP_006339.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COG5 | ENST00000297135.9 | c.1415_1416insC | p.Gly474TrpfsTer3 | frameshift_variant | 13/22 | 1 | NM_006348.5 | ENSP00000297135 | P2 | |
COG5 | ENST00000347053.8 | c.1415_1416insC | p.Gly474TrpfsTer3 | frameshift_variant | 13/21 | 1 | ENSP00000334703 | A2 | ||
COG5 | ENST00000393603.7 | c.1415_1416insC | p.Gly474TrpfsTer3 | frameshift_variant | 13/21 | 1 | ENSP00000377228 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152010Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251298Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135810
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461720Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727184
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152010Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74242
ClinVar
Submissions by phenotype
COG5-congenital disorder of glycosylation Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 03, 2023 | This sequence change creates a premature translational stop signal (p.Gly505Trpfs*3) in the COG5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COG5 are known to be pathogenic (PMID: 23228021). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 431150). This premature translational stop signal has been observed in individual(s) with clinical features of COG5-congenital disorder of glycosylation (PMID: 28708303). This variant is present in population databases (rs773281248, gnomAD 0.02%). - |
Pathogenic, criteria provided, single submitter | clinical testing | Groupe Hospitalier Pitie Salpetriere, UF Genomique du Developpement, Assistance Publique Hopitaux de Paris | Jan 06, 2017 | Intellectual disability - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at